Skip to content

Use of GI Genius™ XR Software in Virtual Reality Headset During Routine Colonoscopy

Pilot Usability Evaluation of GI Genius™ XR Software Running on a Virtual Reality Headset During Routine CRC Screening and Surveillance Colonoscopies

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07220174
Enrollment
15
Registered
2025-10-23
Start date
2025-10-31
Completion date
2026-04-30
Last updated
2025-10-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colonoscopy (Procedure)

Brief summary

This pilot study will evaluate the usability and safety of software GI Genius™ XR in the Apple Vision Pro™ virtual reality headset when used in conjunction with the GI Genius™ system during routine screening and surveillance colonoscopy procedures. GI Genius™ XR enables colonoscopists to view the standard live endoscopic video feed within a virtual reality environment as an alternative to the conventional endoscopy tower display. The system provides a virtual screen that mirrors the tower video output without any image analysis or interpretation, allowing users to adjust screen size and position for optimal visualization and situational awareness.

Interventions

DEVICEsoftware GI Genius™ XR on headset

The screening or surveillance colonoscopy is performed with the endoscopist wearing the headset and using the software GI Genius™ XR.

Sponsors

Cosmo Artificial Intelligence-AI Ltd
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
45 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

for patient: * Male or female aged ≥ 45 years; * Scheduled for routine CRC screening or surveillance colonoscopy; * Written informed consent to participate. Inclusion Criteria for endoscopist: * Male or female board-certified gastroenterologists experienced with CRC screening and surveillance colonoscopy; * Written informed consent to participate.

Exclusion criteria

for patient: * Not able to comply with the protocol requirement; * Implanted or worn medical device (pacemaker, defibrillator, insulin pump, etc.).

Design outcomes

Primary

MeasureTime frameDescription
User feedback on usabilityDay 1Thematic analysis of qualitative feedback on headset integration.
Adverse eventsDay 1Collection and analysis of any adverse event.
GI Genius™ XR critical tasksDay 1Correct execution of critical tasks through a questionnaire
Use effectsDay 1Use effects of the virtual reality headset on endoscopists through a questionnaire.
Problem resolution processDay 1Management of non-specific problem resolution through a questionnaire.
Time managementDuring the procedureTime to complete key tasks during the procedure.
Interruption managementDay 1Number and severity of interruptions related to headset messages or other user device interactions.

Secondary

MeasureTime frameDescription
System Usability ScoreThrough study completion, an average of 3 monthsSystem Usability Score questionnaire across all participating endoscopists on a \[0-100\] scale, where 100 is the maximum positive outcome.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026